Liver cancer ablation with extracorporeal high-intensity focused ultrasound.
Recent animal studies have demonstrated the capacity of high-intensity focused ultrasound (HIFU) to extracorporeally ablate selective tissue targets in the liver without requiring surgical exposure of the liver or insertion of instruments into the liver. The potential value of HIFU as a noninvasive local treatment for human hepatic cancers has attracted considerable interest. This report reviews the current status of HIFU research and sets forth questions for future study.
Yang
R
R
Department of Surgery, Indiana University School of Medicine, Indianapolis.
Sanghvi
N T
NT
Rescorla
F J
FJ
Kopecky
K K
KK
Grosfeld
J L
JL
D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D006979:Hyperthermia, Induced; D008099:Liver / Q000473:pathology*; D008113:Liver Neoplasms / Q000098:blood supply / Q000473:pathology / Q000628:therapy*; D008991:Monitoring, Physiologic; D014464:Ultrasonic Therapy / Q000379:methods*